Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.21 USD | 0.00% | +0.36% | +30.82% |
Apr. 24 | Argan: successful 150 ME capital increase | CF |
Apr. 19 | Argan Insider Sold Shares Worth $899,850, According to a Recent SEC Filing | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's profit outlook over the next few years is a strong asset.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Construction & Engineering
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+30.82% | 810M | C | ||
-3.12% | 67.32B | C+ | ||
+2.91% | 60.23B | C+ | ||
+18.25% | 37.36B | B+ | ||
+9.98% | 30.39B | B | ||
+2.06% | 26.44B | A- | ||
+22.18% | 21.89B | B- | ||
+15.03% | 19.45B | A | ||
+23.56% | 17.3B | B+ | ||
+62.16% | 16.42B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AGX Stock
- Ratings Argan, Inc.